Citation tools
"Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria." Drug Metabolism and Disposition
41.7
(2013):
1347-1366.
Web. 03 Dec. 2023.